Skip to main content

SlateStone Wealth, LLC

SEC CIK
0001764049
Latest filing
Jul 20, 2026

ABT holding history

Abbott Laboratories in every 13F filed by SlateStone Wealth, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
35,846
Value
$3.25M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by SlateStone Wealth, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202635,846$3.25M0.2%−3,350−8.5%ReducedHolders
Q1 202639,196$4.02M0.3%−322−0.8%ReducedHolders
Q4 202539,518$4.95M0.4%−592−1.5%ReducedHolders
Q3 202540,110$5.37M0.5%−149−0.4%ReducedHolders
Q2 202540,259$5.48M0.5%−425−1.0%ReducedHolders
Q1 202540,684$5.40M0.5%−130−0.3%ReducedHolders
Q4 202440,814$4.62M0.5%+462+1.1%AddedHolders
Q3 202440,352$4.60M0.4%−7,796−16.2%ReducedHolders
Q2 202448,148$5.00M0.5%+405+0.8%AddedHolders
Q1 202447,743$5.43M0.5%+6,443+15.6%AddedHolders
Q4 202341,300$4.55M0.6%−433−1.0%ReducedHolders
Q3 202341,733$4.04M0.6%+28,259+209.7%AddedHolders
Q2 202313,474$1.47M0.3%−220−1.6%ReducedHolders
Q1 202313,694$1.39M0.3%−451−3.2%ReducedHolders
Q4 202214,145$1.55M0.4%+3,756+36.2%AddedHolders
Q3 202210,389$1.00M0.3%−7,565−42.1%ReducedHolders
Q2 202217,954$1.95M0.5%−1,695−8.6%ReducedHolders
Q1 202219,649$2.33M0.5%−4,915−20.0%ReducedHolders
Q4 202124,564$3.46M0.7%+14,156+136.0%AddedHolders
Q3 202110,408$1.23M0.3%+1,585+18.0%AddedHolders
Q2 20218,823$1.02M0.2%+4,305+95.3%AddedHolders
Q1 20214,518$541.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.